Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Vascular Calcification in CKD
NCT06903689Phase 2Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of pentoxifylline in Vascular calcification (2 arms), sponsored by Mansoura University. Primary endpoint: Change in Agatston Coronary Artery Calcification Score at 6 months. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
pentoxifylline
03
Conditions
Vascular calcification
Beyond the preview
Go deeper on NCT06903689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06903689.